New Anticancer Theobromine Derivative Targeting EGFR(WT) and EGFR(T790M): Design, Semi-Synthesis, In Silico, and In Vitro Anticancer Studies

Based on the pharmacophoric features of EGFR inhibitors, a new semisynthetic theobromine-derived compound was designed to interact with the catalytic pocket of EGFR. Molecular docking against wild (EGFR(WT); PDB: 4HJO) and mutant (EGFR(T790M); PDB: 3W2O) types of EGFR-TK indicated that the designed...

Descripción completa

Detalles Bibliográficos
Autores principales: Elkaeed, Eslam B., Yousef, Reda G., Elkady, Hazem, Alsfouk, Aisha A., Husein, Dalal Z., Ibrahim, Ibrahim M., Metwaly, Ahmed M., Eissa, Ibrahim H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500845/
https://www.ncbi.nlm.nih.gov/pubmed/36144596
http://dx.doi.org/10.3390/molecules27185859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500845/
https://www.ncbi.nlm.nih.gov/pubmed/36144596
http://dx.doi.org/10.3390/molecules27185859

Ejemplares similares